Neurotez Inc. is developing a Leptin product as a hormone replacement therapy for Alzheimers disease.

Biotechnology

Health Care

Therapeutics

Neurotez,Inc.

Neurotez,Inc.'s headquarters in Bridgewater, NJ, United States

Nikolaos Tezapsidis

J. Wesson Ashford

James Harris

Jukka Karjalainen

Arthur Klausner

Nikolaos Robakis

Robert Winkler

Lex Van der Ploeg

Julio Licinio

Bob Oliver

Thomas J. Humphries

Daniel P. Van Kammen

The Advisory Team at Neurotez Inc. offers expert guidance and strategic insights to support the development of the company's Leptin hormone replacement therapy for Alzheimer's disease. Comprising seasoned advisors, the team provides critical feedback on clinical trials, regulatory pathways, and market strategies to ensure successful product development and commercialization.

Advisory Team

The Leadership Team at Neurotez Inc. drives strategic direction and oversees the development of Leptin hormone replacement therapy for Alzheimer's disease. Composed of top executives, including the CEO and CFO, they collaborate on critical decision-making, ensure operational efficiency, and guide cross-functional initiatives to advance the company's mission. Their collective expertise supports innovation and regulatory compliance, ultimately aiming to improve patient outcomes in neurodegenerative disorders.

Leadership Team

Neurotez,Inc.

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Neurotez,Inc.

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Related companies